A. Seilicovich et al., NITRIC-OXIDE INHIBITS THE RELEASE OF NOREPINEPHRINE AND DOPAMINE FROMTHE MEDIAL BASAL HYPOTHALAMUS OF THE RAT, Proceedings of the National Academy of Sciences of the United Statesof America, 92(24), 1995, pp. 11299-11302
Previous research indicates that norepinephrine and dopamine stimulate
release of luteinizing hormone (LH)-releasing hormone (LHRH), which t
hen reaches the adenohypophysis via the hypophyseal portal vessels to
release LH. Norepinephrine exerts its effect via alpha(1)-adrenergic r
eceptors, which stimulate the release of nitric oxide (NO) from nitric
oxidergic (NOergic) neurons in the medial basal hypothalamus (MBH). Th
e NO activates guanylate cyclase and cyclooxygenase, thereby inducing
release of LHRH into the hypophyseal portal vessels. We tested the hyp
othesis that these two catecholamines modulate NO release by local fee
dback. MBH explants were incubated in the presence of sodium nitroprus
side (NP), a releaser of NO, and the effect on release of catecholamin
es was determined. NP inhibited release of norepinephrine. Basal relea
se was increased by incubation of the tissue with the NO scavenger hem
oglobin (20 mu g/ml). Hemoglobin also blocked the inhibitory effect of
NP. In the presence of high-potassium (40 mM) medium to depolarize ce
ll membranes, norepinephrine release was increased by a factor of 3, a
nd this was significantly inhibited by NP. Hemoglobin again produced a
further increase in norepinephrine release and also blocked the actio
n of NP. When constitutive NO synthase was inhibited by the competitiv
e inhibitor N-G-monomethyl-L-arginine (NMMA) at 300 mu M, basal releas
e of norepinephrine was increased, as was potassium-evoked release, an
d this was associated in the latter instance with a decrease in tissue
concentration, presumably because synthesis did not keep up with the
increased release in the presence of NMMA. The results were very simil
ar with dopamine, except that reduction of potassium-evoked dopamine r
elease by NP was not significant, However, the increase following incu
bation with hemoglobin was significant, and hemoglobin, when incubated
with NP, caused a significant elevation in dopamine release above tha
t with NP alone. In this case, NP increased tissue concentration of do
pamine along with inhibiting release, suggesting that synthesis contin
ued, thereby raising the tissue concentration in the face of diminishe
d release. When the tissue was incubated with NP plus hemoglobin, whic
h caused an increase in release above that obtained with NP alone, the
tissue concentration decreased significantly compared with that in th
e absence of hemoglobin, indicating that, with increased release, rele
ase exceeded synthesis, causing a fall in tissue concentration. When N
O synthase was blocked by NMMA, the release of dopamine, under either
basal or potassium-evoked conditions, was increased. Again, in the lat
ter instance the tissue concentration declined significantly, presumab
ly because synthesis did not match release. Therefore, the results wer
e very similar with both catecholamines and indicate that NO acts to s
uppress release of both amines. Since both catecholamines activate the
release of LHRH, the inhibition of their release by NO serves as an u
ltra-short-loop negative feedback by which NO inhibits the release of
the catecholamines, thereby reducing the activation of the NOergic neu
rons and decreasing the release of LHRH. This may be an important mean
s for terminating the pulses of release of LHRH, which generate the pu
lsatile release of LH that stimulates gonadal function in both male an
d female mammals.